Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Halozyme Therapeutics

Halozyme Therapeutics reported $8.7M in Trade Creditors for its fiscal quarter ending in March of 2023.

Trade Creditors Change
Acadia Pharmaceuticals ACAD:US USD 17.42M 4.68M
Agios Pharmaceuticals AGIO:US USD 8.66M 9.95M
Alnylam Pharmaceuticals ALNY:US USD 62.24M 35.86M
Amarin AMRN:US USD 58.78M 5.82M
Baxter International BAX:US USD 1.29B 151M
Cara Therapeutics CARA:US USD 4.42M 5.18M
Cytokinetics CYTK:US USD 17.36M 8.25M
DBV Technologies DBVT:US USD 19.94M 5.46M
Eli Lilly LLY:US USD 2.02B 85.3M
Esperion Therapeutics ESPR:US USD 17.06M 5.98M
Halozyme Therapeutics HALO:US USD 8.7M 9M
Immunogen IMGN:US USD 32.26M 13.09M
Intercept Pharmaceuticals ICPT:US USD 12.74M 1.49M
Intra Cellular Therapies ITCI:US USD 8.44M 1.95M
Intrexon XON:US USD 3.81M 259K
Ionis Pharmaceuticals IONS:US USD 10.5M 7.42M
MannKind MNKD:US USD 13.89M 2.84M
Minerva Neurosciences NERV:US USD 961K 9K
Nektar Therapeutics NKTR:US USD 3.7M 9.28M
Peregrine Pharmaceuticals PPHM:US USD 36.39M 13.06M
Rigel Pharmaceuticals RIGL:US USD 6.3M 16.21M
Vanda Pharmaceuticals VNDA:US USD 3.42M 1.56M